| Literature DB >> 29285568 |
Toshihide Toriyama1, Tetsuyoshi Horiuchi2, Kazuhiro Hongo3.
Abstract
BACKGROUND: Migraineurs exhibit pain hypersensitivity throughout the body during and between migraine headaches. Migraine is classified as a central sensitivity syndrome, typified by fibromyalgia showing widespread pressure hyperalgesia determined by a tender point. This study was performed to examine whether: 1) there is a subgroup of episodic migraineurs with widespread pressure hyperalgesia during and between attacks; 2) if such a subgroup exists, what is the prevalence and what is the difference between groups with interictal widespread hyperalgesia and acute allodynia regarding the demographic and clinical characteristics of migraine.Entities:
Keywords: Allodynia; Central sensitization; Fibromyalgia; Hyperalgesia; Migraine; Pain thresholds; Tender point
Mesh:
Year: 2017 PMID: 29285568 PMCID: PMC5745372 DOI: 10.1186/s10194-017-0824-0
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Comparison between the positive tender point (TP) count in migraineurs and those of controls
| Migraineurs | Controls |
| |
|---|---|---|---|
| Positive TP count | 6.3 ± 4.3 | 1.7 ± 2.4 |
|
Values are absolute numbers and mean ± SD
uMann-Whitney U test
Comparison between the positive TP count in migraineurs and those of controls separated by gender
| Migraineurs |
| Controls |
| |||
|---|---|---|---|---|---|---|
| Gender | Female ( | Male ( | Female ( | Male ( | ||
| Positive TP count | 6.6 ± 4.4 | 4.4 ± 3.4 | 0.012u | 1.8 ± 2.5 | 0.8 ± 1.9 | 0.028u |
Fig. 1Distribution of number of positive tender point of controls. The cutoff value for WPH responder was defined as the total TPC below which 95% of control subjects responded. This cutoff value was 7
Fig. 2The percentage of migraine patients (left bars) and controls (right bars) with positive tender point sites examined, arranged in sequence from highest to lowest for controls. White bars and gray and bars indicate right and left, respectively. * p < 0.001, χ2 test
Baseline characteristics of 176 migraine patient, separated by the presence of interictal widespread hyperalgesia (left) and acute allodynia (right)
| Migraine without IWH | Migraine with IWH |
| Migraine without ACA | Migraine with ACA |
| |
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| Variables | ||||||
| General variables | ||||||
| Female gender | 80 (78.4%) | 68 (91.9%) |
| 45 (73.8%) | 103 (89.6%) |
|
| Age (years) | 39.9 ± 9.7 | 37.4 ± 10.6 | 0.106t | 39.4 ± 11.0 | 38.5 ± 9.7 | 0.595t |
| Migraine-specific variables | ||||||
| Migraine type | 0.703x |
| ||||
| Migraine without aura | 62 (60.8%) | 42 (56.8%) | 43 (70.5%) | 61 (53.0%) | ||
| Migraine with aura | 40 (39.2%) | 32 (43.2%) | 18 (29.5%) | 54 (47.0%) | ||
| Age at migraine onset (years) | ||||||
| less than 15 | 18 (17.6%) | 22 (29.7%) |
| 13 (21.3%) | 27 (23.5%) |
|
| 15-19 | 26 (25.5%) | 20 (27.0%) | 9 (14.8%) | 37 (32.2%) | ||
| 20-24 | 17 (16.7%) | 12 (16.2%) | 9 (14.8%) | 20 (17.4%) | ||
| 25-29 | 7 (6.9%) | 9 (12.2%) | 8 (13.1%) | 8 (7.0%) | ||
| 30 or more | 34 (33.3%) | 11 (14.9%) | 22 (36.1%) | 23 (20.0%) | ||
| Migraine duration (years) | ||||||
| less than10 | 27 (26.5%) | 15 (20.3%) | 0.351x | 22 (36.1%) | 20 (17.4%) |
|
| 10-19 | 35 (34.3%) | 33 (44.6%) | 18 (29.5%) | 50 (43.5%) | ||
| 20-29 | 27 (26.5%) | 14 (18.9%) | 15 (24.6%) | 26 (22.6%) | ||
| 30 or more | 13 (12.7%) | 12 (16.2%) | 6 (9.8%) | 19 (16.5%) | ||
| Duration of headache attack (hours) | 0.884x | 0.456x | ||||
| 12 or less | 46 (45.1%) | 35 (47.3%) | 30 (49.2%) | 51 (44.3%) | ||
| 13-24 | 40 (39.2%) | 25 (33.8%) | 24 (39.3%) | 41 (35.7%) | ||
| 25-48 | 9 (8.8%) | 8 (10.8%) | 3 (4.9%) | 14 (12.2%) | ||
| more than 48 | 7 (6.9%) | 6 (8.1%) | 4 (6.6%) | 9 (7.8%) | ||
| Frequency of headache (no/year) |
|
| ||||
| 1-6 | 23 (22.5%) | 6 (8.1%) | 16 (26.2%) | 13 (11.3%) | ||
| 7-12 | 20 (19.6%) | 11 (14.9%) | 11 (18.0%) | 20 (17.4%) | ||
| 13-54 | 51 (50.0%) | 40 (54.1%) | 31 (50.8%) | 60 (52.2%) | ||
| more than 54 | 8 (7.8%) | 17 (23.0%) | 3 (4.9%) | 22 (19.1%) | ||
| Headache intensity | 0.621f | 0.486f | ||||
| Mild | 4 (3.9%) | 1 (1.4%) | 2 (3.3%) | 3 (2.6%) | ||
| Moderate | 40 (39.2%) | 28 (37.8%) | 27 (44.3%) | 41 (35.7%) | ||
| Severe | 58 (56.9%) | 45 (60.8%) | 32 (52.5%) | 71 (61.7%) | ||
| Headache disability (HIT-6) | 0.056x |
| ||||
| severe (60 or more) | 56 (54.9%) | 52 (70.3%) | 28 (5.9%) | 80 (69.6%) | ||
| Acute cutaneous allodynia (yes) | 59 (57.8%) | 56 (75.7%) |
| – | – | |
| Interictal WPH (yes) | – | – | 18 (29.5%) | 56 (48.7%) |
| |
| Migraine-associated symptoms | ||||||
| Nausea/Vomiting | 96 (94.1%) | 69 (93.2%) | 1f | 58 (95.1%) | 107 (93.0%) | 0.75 f |
| Photophobia | 76 (74.5%) | 62 (83.8%) | 0.197x | 37 (60.7%) | 101 (87.8%) |
|
| Phonophobia | 62 (60.8%) | 56 (75.7%) | 0.056x | 27 (44.3%) | 91 (79.1%) |
|
| Osmophobia | 44 (43.1%) | 37 (50.0%) | 0.454x | 21 (34.4%) | 60 (52.2%) |
|
| Depression (SDS48 or more) | 15 (14.7%) | 23 (31.1%) |
| 10 (16.4%) | 28 (24.3%) | 0.304x |
| Use of medication | ||||||
| Use of acute medication | 14 (13.7%) | 13 (17.6%) | 0.627x | 9 (14.8%) | 18 (15.7%) | 1x |
| Use of a triptan | 45 (44.1%) | 33 (44.6%) | 1x | 22 (36.1%) | 56 (48.7%) | 0.148x |
| Use of prophylactic drugs | 6 (5.9%) | 11 (14.9%) | 0.083x | 4 (6.6%) | 13 (11.3%) | 0.455x |
Values are absolute numbers with corresponding % or means ±SD
p-values depicted in bold italic indicate significant difference (p < 0.05)
IWH interictal widespread hyperalgesia, ACA acute cutaneous allodynia, HIT-6 headache impact test, SDS self-rating depression scale
xχ2 test
fFisher’s exact test
tt-test
Multivariate logistic regression model – factors associated with IWPH among those with episodic migraine
| Variable | Odds ratio | 95% IC |
| |
|---|---|---|---|---|
| Gender (female versus male) | 3.47 | 1.17-10.3 | 0.025 | |
| Age at onset migraine (year) | ||||
| 15-19 vs. less than 15 | 0.56 | 0.23-1.38 | 0.3 | |
| 20-24 vs. less than 15 | 0.59 | 0.22-1.62 | 0.31 | |
| 25-29 vs. less than 15 | 1.38 | 0.38-4.98 | 0.63 | |
| 30 or more vs. less than 15 | 0.242 | 0.09-0.66 | 0.005 | |
| Migraine frequency (attacks per year) | ||||
| 7-12 vs. 1-6 | 1.58 | 0.46-5.48 | 0.47 | |
| 13-54 vs. 1-6 | 2.06 | 0.72- 5.89 | 0.18 | |
| more than 54 vs. 1-6 | 8.75 | 2.34-32.7 | 0.001 | |
Independent variables with P < 0.15 on univariate analysis were introduced into the model: female gender, current age, age at migraine onset, frequency of headache, headache disability, cutaneous allodynia, phonophobia, depression and use of prophylactic medicine
Comparison between sites sorted in descending order of prevalence of positive TP of our controls and sites arranged in ascending order of PPT of controls in previous studies
| Descending order of prevalence of positive TP of our controls | Ascending order of PPT of controls of Marques et al. [ | Ascending order of PPT of controls of Tastekin et al. [ |
|---|---|---|
| Second Rib | Second Rib | Occiput |
| Low Cervical | Low Cervical | Low Cervical |
| Trapezius | Occiput | Second Rib |
| Lateral Epicondyle | Lateral Epicondyle | Knee |
| Occiput | Trapezius | Trapezius |
| Greater Trochanter | Knee | Lateral Epicondyle |
| Supraspinatus | Supraspinatus | Supraspinatus |
| Gluteal | Gluteal | Greater Trochanter |
| Knee | Greater Trochanter | Gluteal |
Comparison between sites sorted in descending order of prevalence of positive TP of our migraineurs and sites arranged in descending order of PPT of FM patients in previous studies
| Descending order of prevalence of positive TP of our migraineurs | Ascending order of PPT of FM patients of Marques et al. | Ascending order of PPT of FM patients of Tastekin et al. |
|---|---|---|
| Low Cervical | Second Rib | Second Rib |
| Second Rib | Low Cervical | Low Cervical |
| Lateral Epicondyle | Lateral Epicondyle | Occiput |
| Trapezius | Occiput | Lateral Epicondyle |
| Occiput | Supraspinatus | Knee |
| Supraspinatus | Knee | Trapezius |
| Gluteal | Trapezius | Supraspinatus |
| Knee | Gluteal | Greater Trochanter |
| Greater Trochanter | Greater Trochanter | Gluteal |